This compound is a pharmaceutical intermediate specifically used in the manufacturing process of baloxavir marboxil, an antiviral agent. It features a complex polycyclic structure containing multiple aromatic rings, halogen atoms, and stereocenters, as confirmed by analytical data.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1985606-53-8
(R)-12-((S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
pharmaceutical intermediate
Baloxavir marboxil
active pharmaceutical ingredient
Baloxavir
antiviral active pharmaceutical ingredient
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
Pharmaceutical intermediate for baloxavir marboxil
3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
Pharmaceutical intermediate for baloxavir marboxil
2-(2-aminoethoxy)-1,1-dimethoxyethane
Pharmaceutical intermediate for baloxavir marboxil
2-Pyridinecarboxylic acid, 1-amino-1,4-dihydro-4-oxo-3-(phenylmethoxy)-, ethyl ester
pharmaceutical intermediate
7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol
pharmaceutical intermediate
(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
DFYPBBJPWOUUJP-IAPPQJPRSA-N
C1COC[C@@H]2N1C(=O)C3=C(C(=O)C=CN3N2[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)OCC7=CC=CC=C7
—